Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GRT9906 Prolonged Release Tablets After Dose Escalation in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2004

Primary Completion Date

March 23, 2005

Study Completion Date

March 23, 2005

Conditions

Pharmacokinetics

Interventions

DRUG

GRT9906 PR tablet

40 mg GRT9906 PR tablet oral (minimal release of 80 percent after 480 minutes)

DRUG

Placebo

Placebo tablet matching 40 mg GRT9906 PR tablet

Trial Locations (1)

FOCUS Clinical Drug Development GmbH, Neuss